KIMES

ADM Bioscience Co., Ltd. is a research institute company that seeks to create new technologies through the convergence of bio and nanotechnology established by CRO ADM Korea Co., Ltd. and KIMM, and has and has the original patented technology of the microneedle manufacturing method applied to PDRN. 'MICRO SPINE(TM) PATCH' is a platform technology that attaches API to the skin in the form of PATCH and absorbs effective substances without pain by mounting API in PDRN, a safe raw material with proven medical effects such as skin regeneration, and It is a next-generation drug delivery system that combines ADM Bioscience's own technology.